Skip to content
Screener

Vir Biotechnology, Inc. VIR Total Cost of Revenue

Total Cost of Revenue at other companies

Amgen logo
AmgenAMGN
$2.81B-6.6%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$100.7M+69.6%
Gilead Sciences logo
Gilead SciencesGILD
$1.58B+5.2%

Segments

By segment

See full
Reportable Segment$0-100%

Other financials

Income statement

See full
Revenue$238.9M+19,583%
Gross profit$238.9M+19,763%
Operating income$73.5M+162%
Net income$80.1M+172%
EPS (diluted)$0.47+159%

Balance sheet

See full
Cash & equivalents$287.6M-6.1%
Total debt$93.3M-8.8%
Total equity$982.5M+3.7%
Total assets$1.2B+1.9%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$32.0K-98.7%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.48B+111%
Enterprise value$1.29B+159%
P/S4.9×-32.1×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-92.4%-45.5pp
Net margin-83%-40.9pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-26.1%-7.9pp
Debt / equity0.1×0.0×
Current ratio-1.0×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053549
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Segment revenue$238,946$1,214$238,917$4,246
Less: Segment expenses (1)
Cost of revenue1111
Research and development
Contract manufacturing23,96714,06359,97423,399
Personnel (2)28,51233,16560,04066,883
Clinical costs22,53220,36148,66640,967
Licenses, collaborations and contingent consideration, net41,21111,30138,40247,892

Item 1. Financial Statements (unaudited)

FAQ

What is Vir Biotechnology, Inc.'s total cost of revenue?
Vir Biotechnology, Inc. (VIR) reported total cost of revenue of $0 in Q2 2026.
How has Vir Biotechnology, Inc.'s total cost of revenue changed year-over-year?
Vir Biotechnology, Inc.'s total cost of revenue decreased by 100.0% year-over-year, from $11K to $0.
What is the long-term trend for Vir Biotechnology, Inc.'s total cost of revenue?
Over 3 years (2021 to 2024), Vir Biotechnology, Inc.'s total cost of revenue has grown at a -76.6% compound annual growth rate (CAGR), from $65.86M to $845K.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about Vir Biotechnology, Inc.'s total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude